Joachim Sieper
Impact in
- Rheumatology top 0.01%
- Spondyloarthritis Studies and Treatments
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
- Hematology top 0.05%
- Autoimmune and Inflammatory Disorders Research
Papers in
- Rheumatology 490
- Spondyloarthritis Studies and Treatments 457
- Rheumatoid Arthritis Research and Therapies 185
- Systemic Lupus Erythematosus Research 21
- Immunology 124
- Psoriasis: Treatment and Pathogenesis 100
- T-cell and B-cell Immunology 10
- Co-authors
- Jürgen Braun (175 shared papers)Martín Rudwaleit (152 shared papers)Joachim Listing (74 shared papers)Denis Poddubnyy (103 shared papers)Désirée van der Heijde (69 shared papers)Xenofon Baraliakos (52 shared papers)Maxime Dougados (37 shared papers)Hildrun Haibel (77 shared papers)
- Journals
- Annals of the Rheumatic Diseases (127 papers)Lara D. Veeken (39 papers)Arthritis Research & Therapy (24 papers)RMD Open (21 papers)The Journal of Rheumatology (20 papers)
- Partner nations
- GermanyUnited StatesNetherlands
In The Last Decade
Joachim Sieper
533 papers receiving 53.9k citations
Joachim Sieper's Hit Papers
Peers
Comparison fields: 5 of 172
- Rheumatology 42.0k
- Hematology 8.3k
- Immunology 14.7k
- Orthopedics and Sports Medicine 3.6k
- Pharmacology 4.2k
Countries citing papers authored by Joachim Sieper
This map shows the geographic impact of Joachim Sieper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joachim Sieper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joachim Sieper more than expected).
Fields of papers citing papers by Joachim Sieper
This network shows the impact of papers produced by Joachim Sieper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joachim Sieper. The network helps show where Joachim Sieper may publish in the future.
Co-authors
The 25 scholars most cited alongside Joachim Sieper, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 553 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | What low back pain is and why we need to pay attention Hit paper breakdown → | 2018 | 3193 |
| 2 | The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection Hit paper breakdown → | 2009 | 2812 |
| 3 | Prevention and treatment of low back pain: evidence, challenges, and promising directions Hit paper breakdown → | 2018 | 1666 |
| 4 | Ankylosing spondylitis Hit paper breakdown → | 2007 | 1476 |
| 5 | The Assessment of SpondyloArthritis international Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general Hit paper breakdown → | 2010 | 1297 |
| 6 | The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis Hit paper breakdown → | 2009 | 1287 |
| 7 | Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial Hit paper breakdown → | 2002 | 1060 |
| 8 | Axial spondyloarthritis Hit paper breakdown → | 2017 | 1013 |
| 9 | Low back pain: a call for action Hit paper breakdown → | 2018 | 914 |
| 10 | Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis Hit paper breakdown → | 2015 | 828 |
| 11 | Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis Hit paper breakdown → | 2008 | 826 |
| 12 | Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors Hit paper breakdown → | 1998 | 761 |
| 13 | The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal Hit paper breakdown → | 2009 | 729 |
| 14 | Efficacy and safety of adalimumab in patients with ankylosing spondylitis: Results of a multicenter, randomized, double‐blind, placebo‐controlled trial Hit paper breakdown → | 2006 | 724 |
| 15 | European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update Hit paper breakdown → | 2016 | 724 |
| 16 | Efficacy and safety of infliximab in patients with ankylosing spondylitis: Results of a randomized, placebo‐controlled trial (ASSERT) Hit paper breakdown → | 2005 | 722 |
| 17 | Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI group Hit paper breakdown → | 2009 | 716 |
| 18 | The early disease stage in axial spondylarthritis: Results from the german spondyloarthritis inception cohort Hit paper breakdown → | 2009 | 581 |
| 19 | Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force Hit paper breakdown → | 2017 | 525 |
| 20 | ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis Hit paper breakdown → | 2008 | 511 |
About Joachim Sieper
Joachim Sieper is a scholar working on Rheumatology, Immunology, Hematology, Orthopedics and Sports Medicine and Pathology and Forensic Medicine, having authored 553 papers that have together received 56.3k indexed citations. Recurring topics across this work include Spondyloarthritis Studies and Treatments (457 papers), Rheumatoid Arthritis Research and Therapies (185 papers), Psoriasis: Treatment and Pathogenesis (100 papers), Autoimmune and Inflammatory Disorders Research (59 papers), Bone and Joint Diseases (27 papers), Systemic Lupus Erythematosus Research (21 papers), T-cell and B-cell Immunology (10 papers) and Dermatology and Skin Diseases (9 papers). The work is most often cited by research in Rheumatology (42.0k citations), Hematology (8.3k citations), Immunology (14.7k citations), Orthopedics and Sports Medicine (3.6k citations) and Pharmacology (4.2k citations). Joachim Sieper has collaborated with scholars based in Germany, United States and Netherlands. Frequent co-authors include Jürgen Braun, Martín Rudwaleit, Joachim Listing, Denis Poddubnyy, Désirée van der Heijde, Xenofon Baraliakos, Maxime Dougados, Hildrun Haibel, Jan Brandt and Robert Landewé. Their work appears in journals such as Annals of the Rheumatic Diseases, Lara D. Veeken, Arthritis Research & Therapy, RMD Open and The Journal of Rheumatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.